| Quarterly Financials | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 1,566 | 1,576 | 1,918 | 1,839 | 1,797 | 1,853 | 2,156 | 2,209 | 2,032 | 2,091 | 2,326 | 2,307 | 1,768 | 2,252 | 2,234 | 2,421 | 2,381 | 2,515 | 2,662 | 2,750 | 2,699 | 2,835 | 3,202 | 956 | 849 | 933 | 1,108 | 978 | 6,122 | 1,122 | 1,083 | 1,032 | 1,111 |
| Expenses | 1,517 | 1,428 | 1,643 | 1,521 | 1,651 | 1,714 | 1,891 | 1,851 | 1,806 | 1,842 | 1,955 | 1,878 | 1,618 | 1,972 | 1,900 | 2,070 | 2,091 | 2,162 | 2,253 | 2,267 | 2,370 | 2,498 | 2,744 | 687 | 747 | 856 | 806 | 861 | 841 | 869 | 888 | 845 | 881 |
| EBITDA | 49 | 148 | 276 | 318 | 146 | 139 | 265 | 358 | 226 | 249 | 371 | 429 | 150 | 280 | 335 | 351 | 290 | 353 | 409 | 482 | 329 | 337 | 458 | 269 | 102 | 78 | 302 | 117 | 5,281 | 252 | 195 | 187 | 230 |
| Operating Profit % | 3 % | 9 % | 9 % | 15 % | 7 % | 7 % | 12 % | 16 % | 11 % | 12 % | 16 % | 18 % | 8 % | 12 % | 15 % | 13 % | 12 % | 14 % | 15 % | 17 % | 11 % | 11 % | 14 % | 15 % | 11 % | 8 % | 16 % | 12 % | 16 % | 20 % | 15 % | 16 % | 18 % |
| Depreciation | 79 | 95 | 68 | 56 | 74 | 76 | 79 | 78 | 126 | 149 | 140 | 171 | 155 | 153 | 157 | 153 | 153 | 156 | 161 | 170 | 175 | 189 | 198 | 54 | 51 | 54 | 57 | 58 | 60 | 62 | 62 | 64 | 63 |
| Interest | 43 | 46 | 49 | 47 | 40 | 40 | 56 | 55 | 88 | 88 | 72 | 112 | 80 | 75 | 62 | 77 | 67 | 61 | 67 | 62 | 69 | 77 | 87 | 25 | 25 | 30 | 25 | 30 | 29 | 32 | 31 | 32 | 31 |
| Profit Before Tax | -73 | 7 | 158 | 216 | 32 | 24 | 130 | 224 | 12 | 12 | 160 | 146 | -85 | 53 | 115 | 122 | 71 | 135 | 181 | 250 | 85 | 71 | 173 | 190 | 26 | -7 | 221 | 28 | 5,191 | 159 | 102 | 91 | 136 |
| Tax | 7 | 9 | -1 | 10 | 12 | 10 | 17 | 4 | 2 | 5 | 8 | -0 | 4 | 10 | 8 | 5 | 11 | 8 | 13 | 4 | 6 | 17 | 14 | 7 | 6 | 8 | 11 | 31 | 39 | 53 | 38 | 5 | 43 |
| Net Profit | -80 | -3 | 159 | 205 | 20 | 14 | 113 | 220 | 10 | 7 | 151 | 146 | -89 | 42 | 107 | 117 | 60 | 128 | 168 | 246 | 80 | 54 | 159 | 183 | 20 | -15 | 209 | -2 | 5,152 | 106 | 64 | 86 | 94 |
| EPS in ₹ | -1.66 | 0.01 | 3.33 | 4.07 | 0.25 | 0.22 | 2.00 | 4.10 | 0.06 | 0.06 | 2.78 | 2.61 | -1.67 | 0.66 | 1.86 | 2.12 | 0.89 | 2.15 | 2.98 | 4.55 | 1.38 | 0.93 | 2.80 | 3.43 | 0.10 | -0.62 | 3.60 | -0.48 | 103.34 | 1.94 | 1.14 | 1.59 | 1.67 |
Aster DM Healthcare
Aster DM Healthcare
700.25
+2.40
(0.34%)
Key Fundamentals
Market Cap
36,157.10 Cr
EPS
107.98
PE Ratio
103.75
Dividend Yield
0.69 %
Industry
Healthcare Services 52 Week High
732.20
52 Week Low
387.10
PB Ratio
10.19
Debt to Equity
0.47
Sector
Hospitals Analyst Rating and Forecast
- By Refinitiv from8 analysts
Actual
Company News
View All News
Aster DM Healthcare shares surged 6% to reach an all-time high of ₹699.55 after ICRA upgraded the company's long-term rating to [ICRA]A+ and short-term rating to [ICRA]A1+. The upgrade was attributed to the company's expanding operational scale, robust financial profile, and strategic growth plans. The healthcare provider reported 11.9% revenue growth in FY25, driven by increased inpatient volumes and improved average revenue per occupied bed. Operating EBITDA margins improved to 19.5% in FY25 and 20% in Q1 FY26. The company benefited from proceeds of its GCC business segregation, which enhanced liquidity for dividends and expansion funding. Aster is merging with Quality Care India Ltd to form Aster DM Quality Care Ltd, expected to become one of India's top three hospital chains. The company plans to add 2,600 beds through various projects. The stock has gained 63% over the past year and 9% in the past four sessions.
Aster DM Healthcare has received no-objection certificates from both BSE and NSE for its proposed merger with Quality Care India. The stock exchange approvals represent a key regulatory milestone in the merger process between the two healthcare companies.
Aster Digital Health CEO Harsha Rajaram Resigns
Sep 30, 2025
Sep 30, 2025Harsha Rajaram has resigned from his position as CEO of Aster Digital Health, a subsidiary of Aster DM Healthcare Ltd.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,179.70 | #1 1,15,346.10 | 100.00 | 7,184.10 | #1 28.65 | 1,076 | 30.34 | 52.52 | |
7,880.50 | 1,12,806.30 | 69.51 | #1 21,994.30 | 14.76 | #1 1,505 | 39.78 | 57.36 | |
1,057.00 | 79,463.10 | 88.55 | 7,849.70 | 13.25 | 809 | #1 53.33 | 56.30 | |
1,355.40 | 36,241.00 | 68.20 | 3,771.40 | 12.59 | 481 | 49.58 | 49.56 | |
700.25 | #5 36,157.10 | #9 103.75 | #5 4,286.70 | #6 15.12 | #7 337 | #10 -98.18 | 58.96 | |
1,776.00 | 35,748.80 | #1 46.16 | 5,575.00 | 12.29 | 790 | -2.38 | 52.49 | |
721.65 | 28,730.00 | 71.51 | 3,067.00 | 21.98 | 415 | -10.71 | 50.16 | |
1,376.60 | 13,811.00 | 54.13 | 1,566.90 | 17.46 | 244 | 35.52 | 51.52 | |
728.50 | 10,164.70 | 249.33 | 2,257.70 | 17.03 | 49 | -55.88 | 60.01 | |
1,546.60 | 9,964.70 | 52.39 | 1,290.20 | 17.77 | 194 | -1.57 | 56.94 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
15.12 %
Net Income Growth
64.48 %
Cash Flow Change
169.34 %
ROE
126.54 %
ROCE
87.55 %
EBITDA Margin (Avg.)
31.50 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 | 6,606 |
| Fixed Assets | 3,520 | 3,738 | 4,289 | 7,124 | 6,749 | 7,009 | 9,052 | 3,175 | 3,920 |
| Current Assets | 2,473 | 2,869 | 3,617 | 4,096 | 3,629 | 4,097 | 4,922 | 14,165 | 1,902 |
| Capital Work in Progress | 290 | 402 | 550 | 736 | 934 | 998 | 279 | 170 | 293 |
| Investments | 32 | 38 | 22 | 34 | 63 | 45 | 80 | 17 | 245 |
| Other Assets | 2,966 | 3,307 | 4,076 | 4,544 | 3,898 | 4,495 | 5,470 | 14,629 | 2,148 |
| Total Liabilities | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 | 6,606 |
| Current Liabilities | 2,201 | 2,224 | 2,668 | 3,722 | 3,196 | 3,559 | 4,655 | 11,288 | 879 |
| Non Current Liabilities | 2,355 | 2,071 | 2,589 | 4,997 | 4,614 | 4,505 | 5,366 | 1,673 | 2,076 |
| Total Equity | 2,251 | 3,190 | 3,680 | 3,719 | 3,834 | 4,483 | 4,861 | 5,030 | 3,651 |
| Reserve & Surplus | 1,034 | 1,953 | 2,334 | 2,401 | 2,501 | 3,080 | 3,574 | 3,686 | 2,554 |
| Share Capital | 403 | 505 | 505 | 497 | 497 | 500 | 500 | 500 | 500 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 5 | -122 | 61 | 33 | -110 | 120 | 65 | 66 | 332 | 82 |
| Investing Activities | -439 | -775 | -1,136 | -522 | -702 | -658 | -333 | -563 | -951 | -878 | 6,015 |
| Operating Activities | 236 | 203 | 361 | 537 | 601 | 1,223 | 1,569 | 1,314 | 1,834 | 158 | 425 |
| Financing Activities | 203 | 578 | 654 | 46 | 134 | -675 | -1,116 | -686 | -817 | 1,053 | -6,358 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Apr 2025 | Jun 2025 | Sept 2025 |
| Promoter | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.89 % | 40.38 % | 40.39 % | 40.39 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 33.09 % | 29.09 % | 29.09 % | 40.21 % | 29.09 % | 33.48 % | 27.08 % | 23.85 % | 22.62 % | 21.66 % | 11.86 % | 19.64 % | 18.72 % |
| DIIs | 7.81 % | 8.73 % | 7.78 % | 7.87 % | 8.12 % | 9.62 % | 8.94 % | 8.93 % | 8.94 % | 8.56 % | 7.64 % | 7.15 % | 13.70 % | 16.35 % | 20.91 % | 22.91 % | 24.59 % | 24.09 % | 25.28 % | 26.32 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 3.70 % | 4.44 % | 4.21 % | 4.33 % | 3.92 % | 3.70 % | 3.43 % | 3.34 % | 3.18 % | 3.39 % | 3.15 % | 2.96 % | 3.09 % | 6.98 % | 5.94 % | 5.04 % | 4.38 % | 4.12 % | 3.94 % | 3.86 % |
| Others | 50.61 % | 48.94 % | 50.12 % | 49.92 % | 50.08 % | 48.80 % | 49.75 % | 16.76 % | 16.92 % | 17.08 % | 7.11 % | 18.93 % | 7.85 % | 7.72 % | 7.42 % | 7.55 % | 7.49 % | 19.56 % | 10.76 % | 10.70 % |
| No of Share Holders | 0 | 78,719 | 93,506 | 87,804 | 80,746 | 80,427 | 78,374 | 80,913 | 82,129 | 71,379 | 67,673 | 67,331 | 80,931 | 2,06,660 | 1,74,171 | 1,59,038 | 1,54,014 | 1,51,664 | 1,48,139 | 1,47,304 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 120 | 5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.82 | 0.72 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 31 Aug 2023 |  Annual General Meeting | NA | 31 Aug 2023 | 312.45 | 331.20 |
| 23 Apr 2024 |  Dividend | ₹ 118.00 /share | 23 Apr 2024 | 475.25 | 513.35 |
| 22 Aug 2024 | Dividend | ₹ 2.00 /share | 22 Aug 2024 | 375.20 | 401.15 |
| 29 Aug 2024 | Annual General Meeting | NA | 29 Aug 2024 | 379.30 | 409.90 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 427.95 | 405.20 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 494.65 | 485.30 |
| 10 Feb 2025 | Dividend | ₹ 4.00 /share | 10 Feb 2025 | 485.30 | 473.20 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 550.10 | 584.15 |
| 30 Jul 2025 | Quarterly Result Announcement | NA | 30 Jul 2025 | 595.05 | 590.95 |
| 28 Aug 2025 | Dividend | ₹ 1.00 /share | 28 Aug 2025 | 584.15 | 601.00 |
| 04 Sept 2025 | Annual General Meeting | NA | 04 Sept 2025 | 590.95 | 620.00 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Monthly Report On Special Window Re-Lodgment Of SharesOct 09, 2025
Oct 09, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementOct 06, 2025
Oct 06, 2025Announcement under Regulation 30 (LODR)-Credit RatingOct 03, 2025
Oct 03, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 20, 2025
Sep 20, 2025Monthly Report On Special Window Re-Lodgment Of SharesSep 18, 2025
Sep 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 12, 2025
Sep 12, 2025Transcript Of The 17Th Annual General Meeting Of The Company Held On September 4 2025Sep 10, 2025
Sep 10, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 05, 2025
Sep 05, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 25, 2025
Aug 25, 2025Intimation Regarding 100 Days Campaign - "SAKSHAM NIVESHAK"Aug 23, 2025
Aug 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Aug 12, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 12, 2025
Aug 12, 2025Reg. 34 (1) Annual Report.Aug 12, 2025
Aug 12, 2025Notice Of 17Th Annual General MeetingAug 12, 2025
Aug 12, 2025General Communication To Shareholders On Deduction Of TDS On Final Dividend For The Financial Year 2024-25Aug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 30, 2025
Jul 30, 2025General UpdatesJul 30, 2025
Jul 30, 2025Record Date For DividendJul 30, 2025
Jul 30, 2025Results-Financial Results For Jun 30 2025Jul 30, 2025
Jul 30, 2025Board Meeting Outcome for Outcome Of Board MeetingJul 30, 2025
Jul 30, 2025General UpdatesJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-AcquisitionJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 25, 2025
Jul 25, 2025Board Meeting Intimation for The Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2025Jul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-AcquisitionJul 22, 2025
Jul 22, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 19, 2025
Jul 19, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 10, 2025
Jul 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Reply On Clarification Sought On Spurt In VolumeJul 04, 2025
Jul 04, 2025Clarification sought from Aster DM Healthcare LtdJul 04, 2025
Jul 04, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Jun 17, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AJun 16, 2025
Jun 16, 2025Intimation Of Approval Received For Listing Of 18607969 Equity Shares Of Rs. 10/- Each Allotted On Preferential BasisJun 06, 2025
Jun 06, 2025Mutual Fund Holdings
Kotak Midcap Fund Direct-Growth 
Quant Small Cap Fund Direct Plan-Growth 
UTI Mid Cap Fund Direct-Growth 
Bandhan Innovation Fund Direct-Growth 
PGIM India Small Cap Fund Direct - Growth 
Baroda BNP Paribas Midcap Fund Direct-Growth 
Axis Momentum Fund Direct - Growth 
Franklin India Multi Cap Fund Direct-Growth 
Nippon India Small Cap Fund Direct- Growth 
Samco Active Momentum Fund Direct - Growth 
Mirae Asset Healthcare Fund Direct - Growth 
ITI Small Cap Fund Direct-Growth 
TRUSTMF Small Cap Fund Direct-Growth 
Baroda BNP Paribas Health and Wellness Fund Direct-Growth 
SBI Healthcare Opportunities Fund Direct Plan-Growth 
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
Aditya Birla Sun Life Nifty Smallcap 50 Index Fund Direct-Growth 
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth Technical Indicators
RSI(14)
Neutral 58.19
ATR(14)
Less Volatile 18.87
STOCH(9,6)
Neutral 68.93
STOCH RSI(14)
Neutral 30.57
MACD(12,26)
Bullish 0.22
ADX(14)
Strong Trend 35.86
UO(9)
Bearish 46.31
ROC(12)
Downtrend And Accelerating -0.10
WillR(14)
Neutral -45.80
About Aster DM Healthcare
Aster DM Healthcare is a healthcare service provider operating in the GCC and India. Founded in 1987 by Dr. Azad Moopen, the company offers a range of healthcare services through a network of hospitals, clinics, pharmacies, and labs. As of March 2023, Aster DM Healthcare operates 32 hospitals, 127 clinics, 521 pharmacies, and 205 labs and patient experience centers across multiple countries. The company provides primary, secondary, tertiary, and quaternary care, as well as healthcare retailing, diagnostic services, digital health, and medical education. In India, Aster DM Healthcare has 17 hospitals with 4,317 beds, and its operations span across several states including Kerala, Karnataka, Maharashtra, Andhra Pradesh, and Telangana. The company also has a significant presence in GCC countries, with hospitals and clinics in UAE, Oman, Qatar, Bahrain, and Kuwait.
Listing Date
26 Feb, 2018(7 Years,
3 days)
Chairperson NameMandayapurath Azad Moopen
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
